Eli Lilly, Glooko Initiate Digital Health Collaboration for Insulin Pens

Eli Lilly has partnered with Glooko to integrate its Tempo insulin pen and Tempo Smart Button accessory with Glooko’s digital health platform, aiming to make insulin management easier for diabetes patients and their healthcare providers.

The two companies will work to integrate Lilly’s insulin pen and its attachable Smart Button with Glooko’s healthcare software, which will assess the personalized healthcare data obtained from the devices.

According to Glooko, its healthcare platforms work with more than 95 percent of diabetes devices globally.